To test whether the Akt signaling pathway was altered by the UA and PTX combination treatment in esophageal cancer cells, p-Akt (ser473), Akt, GSK, and GSK-3β protein levels were examined using western blotting. This evidence concerns the gene AKT1 and esophageal cancer.